Wo er registriert ist
Jedes Register mit der Zahl seiner Arzneimittel und einigen davon.
Kanada
Health Canada · 3 Arzneimittel
- Boostrix-Polio2.5 LF / 0.5 ML + 8 MCG / 0.5 ML + 40 D / 0.5 ML + 8 D / 0.5 ML + 32 D / 0.5 ML + 2.5 MCG / 0.5 ML + 8 MCG / 0.5 ML + 5.0 LF / 0.5 ML · Suspension · Glaxosmithkline INC
- Infanrix-Ipv/Hib30 UNIT / 0.5 ML + 25 MCG / 0.5 ML + 10 MCG / 0.5 ML + 40 UNIT / 0.5 ML + 8 UNIT / 0.5 ML + 32 UNIT / 0.5 ML + 8 MCG / 0.5 ML + 25 MCG / 0.5 ML + 40 UNIT / 0.5 ML · Suspension · Glaxosmithkline INC
- Infanrix-Ipv30 UNIT / 0.5 ML + 25 MCG / 0.5 ML + 40 UNIT / 0.5 ML + 8 UNIT / 0.5 ML + 32 UNIT / 0.5 ML + 8 MCG / 0.5 ML + 25 MCG / 0.5 ML + 40 UNIT / 0.5 ML · Suspension · Glaxosmithkline INC
Alle Arzneimittel mit Inactivated poliovirus type i
Alle Register, seitenweise. Stärken und Packungen stehen auf der Seite des jeweiligen Arzneimittels.
12 Ergebnisse
| Arzneimittel | Register | Stärke | Form | Status | Inhaber |
|---|---|---|---|---|---|
| Boostrix-PolioKombination | Kanada | 2.5 LF / 0.5 ML + 8 MCG / 0.5 ML + 40 D / 0.5 ML + 8 D / 0.5 ML + 32 D / 0.5 ML + 2.5 MCG / 0.5 ML + 8 MCG / 0.5 ML + 5.0 LF / 0.5 ML | Suspension | Im Handel | Glaxosmithkline INC |
| Infanrix-Ipv/HibKombination | Kanada | 30 UNIT / 0.5 ML + 25 MCG / 0.5 ML + 10 MCG / 0.5 ML + 40 UNIT / 0.5 ML + 8 UNIT / 0.5 ML + 32 UNIT / 0.5 ML + 8 MCG / 0.5 ML + 25 MCG / 0.5 ML + 40 UNIT / 0.5 ML | Suspension | Im Handel | Glaxosmithkline INC |
| Infanrix-IpvKombination | Kanada | 30 UNIT / 0.5 ML + 25 MCG / 0.5 ML + 40 UNIT / 0.5 ML + 8 UNIT / 0.5 ML + 32 UNIT / 0.5 ML + 8 MCG / 0.5 ML + 25 MCG / 0.5 ML + 40 UNIT / 0.5 ML | Suspension | Erloschen | Glaxosmithkline INC |
| Imovax PolioKombination | Kanada | 29 UNIT / 0.5 ML + 7 UNIT / 0.5 ML + 26 UNIT / 0.5 ML | Solution | Im Handel | Sanofi Vaccines Canada LTD. |
| Adacel-PolioKombination | Kanada | 2 LF / 0.5 ML + 5 MCG / 0.5 ML + 5 MCG / 0.5 ML + 3 MCG / 0.5 ML + 2.5 MCG / 0.5 ML + 29 UNIT / 0.5 ML + 7 UNIT / 0.5 ML + 26 UNIT / 0.5 ML + 5 LF / 0.5 ML | Suspension | Im Handel | Sanofi Vaccines Canada LTD. |
| Infanrix HexaKombination | Kanada | 25 LF / 0.5 ML + 25 MCG / 0.5 ML + 10 MCG / 0.5 ML + 10 MCG / 0.5 ML + 8 MCG / 0.5 ML + 25 MCG / 0.5 ML + 40 UNIT / 0.5 ML + 8 UNIT / 0.5 ML + 32 UNIT / 0.5 ML + 10 LF / 0.5 ML + 40 MCG / 0.5 ML | Suspension | Im Handel | Glaxosmithkline INC |
| PentacelKombination | Kanada | 15 LF / 0.5 ML + 20 MCG / 0.5 ML + 5 MCG / 0.5 ML + 10 MCG / 0.5 ML + 3 MCG / 0.5 ML + 20 MCG / 0.5 ML + 29 UNIT / 0.5 ML + 7 UNIT / 0.5 ML + 26 UNIT / 0.5 ML + 30 MCG / 0.5 ML + 5 LF / 0.5 ML | Suspension | Im Handel | Sanofi Vaccines Canada LTD. |
| Hexaxim Suspension for Injection in Pre-Filled SyringeKombination | Singapur | 30 Lf (>= 20 IU)/0.5 mL + 25 μg/0.5 mL + 12 μg/0.5 mL + 10 μg/0.5 mL + 25 μg/0.5 mL + 29 DU/0.5 mL + 7 DU/0.5 mL + 26 DU/0.5 mL + 10 Lf (>= 40 IU)/0.5 mL | injection, suspension | Zugelassen | Sanofi-Aventis Singapore Pte. LTD. |
| QuadracelKombination | Kanada | 15 LF / 0.5 ML + 20 MCG / 0.5 ML + 5 MCG / 0.5 ML + 3 MCG / 0.5 ML + 20 MCG / 0.5 ML + 29 UNIT / 0.5 ML + 7 UNIT / 0.5 ML + 26 UNIT / 0.5 ML + 5 LF / 0.5 ML | Suspension | Im Handel | Sanofi Vaccines Canada LTD. |
| Infanrix Hexa VaccineKombination | Singapur | min 30 iu/0.5 ml + 25 mcg/0.5 ml + 10 mcg/0.5 ml + 10 mcg/0.5 ml + 8 mcg/0.5 ml + 25 mcg/0.5 ml + 40 du/0.5 ml + 8 du/0.5 ml + 32 du/0.5 ml + min 40 iu/0.5 ml | injection | Zugelassen | Glaxosmithkline Pte LTD |
| Pentaxim VaccineKombination | Singapur | min. 20 IU (30 Lf)/0.5 mL + 25 μg/0.5 mL + 25 μg/0.5 mL + 29 DU/0.5 mL + 7 DU/0.5 mL + 26 DU/0.5 mL + min. 40 IU (10 Lf) /0.5 mL + 10 μg/0.5 mL + 18 - 30 μg/0.5 mL | injection, powder, for suspension | Zugelassen | Sanofi-Aventis Singapore Pte. LTD. |
| Tetracoq 05 Imovax D.P.T. PolioKombination | Taiwan | 注射劑 | Erloschen | 法台化學股份有限公司 |
Auf einen Blick
- Register
- 1
- Arzneimittel
- 3
- Unternehmen
- 1